KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Account Payables (2017 - 2025)

Historic Change in Account Payables for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $1.6 million.

  • Cardlytics' Change in Account Payables rose 1634000.0% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$514000.0, marking a year-over-year decrease of 13882.18%. This contributed to the annual value of $499000.0 for FY2024, which is 10878.66% up from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Change in Account Payables is $1.6 million, which was up 1634000.0% from -$2.4 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Change in Account Payables ranged from a high of $1.9 million in Q3 2022 and a low of -$2.4 million during Q2 2025
  • Moreover, its 5-year median value for Change in Account Payables was $125000.0 (2024), whereas its average is $48000.0.
  • Per our database at Business Quant, Cardlytics' Change in Account Payables plummeted by 81187.05% in 2021 and then surged by 1634000.0% in 2025.
  • Cardlytics' Change in Account Payables (Quarter) stood at $1.2 million in 2021, then plummeted by 182.43% to -$1.0 million in 2022, then soared by 150.2% to $504000.0 in 2023, then tumbled by 163.69% to -$321000.0 in 2024, then skyrocketed by 612.15% to $1.6 million in 2025.
  • Its Change in Account Payables stands at $1.6 million for Q3 2025, versus -$2.4 million for Q2 2025 and $551000.0 for Q1 2025.